Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.025
+0.005 (0.49%)
At close: Feb 17, 2026, 4:00 PM EST
1.099
+0.074 (7.22%)
After-hours: Feb 17, 2026, 6:54 PM EST

Edesa Biotech Balance Sheet

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Equivalents
12.0510.791.045.367.097.84
Cash & Short-Term Investments
12.0510.791.045.367.097.84
Cash Growth
670.82%940.39%-80.65%-24.39%-9.55%8.67%
Other Receivables
0.430.640.270.631.263.3
Receivables
0.430.640.270.631.263.3
Prepaid Expenses
0.230.080.370.450.750.95
Total Current Assets
12.7211.511.686.449.0912.09
Property, Plant & Equipment
--0.020.10.030.11
Other Intangible Assets
1.951.982.082.182.282.38
Other Long-Term Assets
0.040.040.040.170.17-
Total Assets
14.7113.533.818.8911.5814.58
Accounts Payable
0.761.081.811.752.121.38
Current Portion of Leases
--0.020.070.020.08
Total Current Liabilities
0.761.081.831.822.141.46
Long-Term Leases
---0.02-0.02
Other Long-Term Liabilities
----0.040.05
Total Liabilities
0.761.081.831.842.181.53
Common Stock
57.954.5247.2446.6442.4734.89
Additional Paid-In Capital
15.1214.7513.5813.0411.184.87
Retained Earnings
-68.2-65.91-58.59-52.42-44.04-26.5
Comprehensive Income & Other
-0.17-0.17-0.24-0.21-0.21-0.21
Total Common Equity
4.663.191.987.059.3913.06
Shareholders' Equity
13.9512.451.987.059.3913.06
Total Liabilities & Equity
14.7113.533.818.8911.5814.58
Total Debt
--0.020.090.020.1
Net Cash (Debt)
12.0510.791.025.277.077.74
Net Cash Growth
670.82%960.70%-80.68%-25.52%-8.63%9.79%
Net Cash Per Share
1.761.900.321.843.374.49
Filing Date Shares Outstanding
8.358.333.473.162.761.93
Total Common Shares Outstanding
8.337.143.253.082.381.9
Working Capital
11.9610.43-0.164.616.9510.63
Book Value Per Share
0.560.450.612.293.956.88
Tangible Book Value
2.71.21-0.14.877.1110.68
Tangible Book Value Per Share
0.320.17-0.031.582.995.62
Machinery
---0.050.050.05
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q